Risk Factors for Cytarabine-Induced Cutaneous Toxicity in Patients with Haematological Malignancies

Publisher： Karger

E-ISSN： 1421-9794|60|3|168-173

ISSN： 0009-3157

Source： Chemotherapy, Vol.60, Iss.3, 2015-03, pp. : 168-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malaria Parasitemia Associated with Febrile Neutropenia in African Patients Undergoing Chemotherapy for Haematological Malignancies

By  

Chemotherapy, Vol. 54, Iss. 2, 2008-02 ,pp. : 117-119

Karger

Access to resources Recommend Favorite

Long Non-Coding RNAs in Haematological Malignancies

By Garitano-Trojaola Andoni   Agirre Xabier   Prósper Felipe   Fortes Puri  

International Journal of Molecular Sciences, Vol. 14, Iss. 8, 2013-07 ,pp. : 15386-15422

MDPI

Access to resources Recommend Favorite

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies

By Bishton Mark J.   Johnstone Ricky W.   Dickinson Michael   Harrison Simon   Prince H. Miles  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2674-2688

MDPI

Access to resources Recommend Favorite

Risk Factors for Predicting Severe Neutropenia Induced by Amrubicin in Patients with Advanced Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 6, 2013-01 ,pp. : 419-425

Karger

Access to resources Recommend Favorite

Efficacy of Oral Cytarabine Ocfosfate and Etoposide in the Treatment of Elderly Patients with Higher-Risk Myelodysplastic Syndromes Compared to That in Elderly Acute Myeloid Leukemia Patients

By  

Chemotherapy, Vol. 59, Iss. 2, 2013-09 ,pp. : 152-158

Karger

Access to resources Recommend Favorite